Normothermic intraperitoneal chemotherapy – long term in peritoneal metastases from colorectal cancer – feasibility study

2023-510217-26-00 Protocol NIPEC-OXA Human pharmacology (Phase I) - Other Ongoing, recruiting

Start 14 Nov 2024 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites · Protocol NIPEC-OXA

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Ongoing, recruiting
Participants planned 20
Countries 1
Sites 1

colorectal cancer with peritoneal metastasis

Key facts

Sponsor
Oslo University Hospital HF
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Digestive System Diseases [C06], Diseases [C] - Neoplasms [C04]
Trial duration
14 Nov 2024 → ongoing
Decision date (initial)
2024-11-14
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2023-510217-26-00
EudraCT number
2020-004944-27
ClinicalTrials.gov
NCT05056389

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

colorectal cancer with peritoneal metastasis

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Oslo University Hospital HF

Sponsor organisation
Oslo University Hospital HF
Address
Taarnbygget, Kirkeveien 166 Kirkeveien 166
City
Oslo
Postcode
0450
Country
Norway

Scientific contact point

Organisation
Oslo University Hospital HF
Contact name
Vegar Johansen Dagenborg

Public contact point

Organisation
Oslo University Hospital HF
Contact name
Vegar Johansen Dagenborg

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Norway Ongoing, recruiting 20 1
Rest of world 0

Investigational sites

Norway

1 site · Ongoing, recruiting
Oslo University Hospital HF
Abdominal cancer surgery, Taarnbygget, Kirkeveien 166, Oslo

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Norway 2024-11-14 2024-11-14

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-10-16 Norway Acceptable
2024-11-13
2024-11-14